Pre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor
Open accessThe DOI matches its Crossref record.
Abstract
Splicing of certain pre-mRNA introns is dependent on an enhancer element, which is typically purine-rich. It is generally thought that enhancers increase the use of suboptimal splicing signals, and one specific proposal is that enhancers stabilize binding of U2AF65 to weak polypyrimidine (Py) tracts. Here, we test this model using an IgM pre-mRNA substrate, which contains a well-characterized enhancer. Although the enhancer was required for in vitro splicing, we found it had no effect on U2AF65 binding. Unexpectedly, replacement of the natural IgM Py tract, branchpoint, and 5' splice site with consensus splicing signals did not circumvent the enhancer requirement. These observations led us to identify a novel regulatory element within the IgM M2 exon that acts as a splicing inhibitor; removal of the inhibitor enabled splicing to occur in the absence of the enhancer. The IgM M2 splicing inhibitor is evolutionarily conserved, can inhibit the activity of an unrelated, constitutively spliced pre-mRNA, and acts by repressing splicing complex assembly. Interestingly, the inhibitor itself forms an ATP-dependent complex that contains U2 snRNP. We conclude that splicing of IgM exons M1 and M2 is directed by two juxtaposed regulatory elements-an enhancer and an inhibitor-and that a primary function of the enhancer is to counteract the inhibitor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Mechanisms of Alternative Pre-Messenger RNA Splicing
Black, D. L. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161720 · Cited by 2,704
Listening to silence and understanding nonsense: exonic mutations that affect splicing
Cartegni, L., Chew, S. L., & Krainer, A. R. (2002) · Nature Reviews Genetics · doi:10.1038/nrg775 · Cited by 2,209
“and/or by antagonizing the action of nearby silencer element”
BackgroundUnderstanding alternative splicing: towards a cellular code
Matlin, A. J., Clark, F., & Smith, C. W. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1645 · Cited by 1,305
Pre-mRNA splicing and human disease
Faustino, N. A., & Cooper, T. A. (2003) · Genes & Development · doi:10.1101/gad.1048803 · Cited by 1,256
Sorting out the complexity of SR protein functions
GRAVELEY, B. R. (2000) · RNA · doi:10.1017/s1355838200000960 · Cited by 1,078
Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases
Blencowe, B. J. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01549-8 · Cited by 689
Smith, P. J., Zhang, C., Wang, J., Chew, S. L., Zhang, M. Q., & Krainer, A. R. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl171 · Cited by 515
Functional recognition of the 3′ splice site AG by the splicing factor U2AF35
Wu, S., Romfo, C. M., Nilsen, T. W., & Green, M. R. (1999) · Nature · doi:10.1038/45590 · Cited by 457
Self-citationCell Motility Is Controlled by SF2/ASF through Alternative Splicing of the Ron Protooncogene
Ghigna, C., Giordano, S., Shen, H., Benvenuto, F., Castiglioni, F., Comoglio, P. M., Green, M. R., Riva, S., & Biamonti, G. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.026 · Cited by 389
Self-citationMerendino, L., Guth, S., Bilbao, D., Martínez, C., & Valcárcel, J. (1999) · Nature · doi:10.1038/45602 · Cited by 290
RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons
Fairbrother, W. G., Yeo, G. W., Yeh, R., Goldstein, P., Mawson, M., Sharp, P. A., & Burge, C. B. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh393 · Cited by 289
hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing
Caputi, M., Mayeda, A., Krainer, A. R., & Zahler, A. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.4060 · Cited by 258
Mechanisms of fidelity in pre-mRNA splicing
Reed, R. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00097-1 · Cited by 249
Exonic Splicing Enhancer Motif Recognized by Human SC35 under Splicing Conditions
Liu, H.-X., Chew, S. L., Cartegni, L., Zhang, M. Q., & Krainer, A. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.1063-1071.2000 · Cited by 244
“3), a variant of D2 with two nucleotide changes to introduce a maximum-score consensus (D2C), and a 19-nt SC35 SELEX winner sequence (6-24) described in a previous study (29) were inserted into the IgM M1-M2 minigene in place of the natural ESE in exon M2, and the corresponding transcripts were spliced in nuclear extr…”
BackgroundMethodInfluentialBuilding specificity with nonspecific RNA-binding proteins
Singh, R., & Valcárcel, J. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb961 · Cited by 222
Bourgeois, C. F., Lejeune, F., & Stévenin, J. (2004) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(04)78002-2 · Cited by 212
hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing
Kashima, T., Rao, N., David, C. J., & Manley, J. L. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm276 · Cited by 212
“PTB depletion (Fig.”
BackgroundInfluentialA Global Regulatory Mechanism for Activating an Exon Network Required for Neurogenesis
Raj, B., Irimia, M., Braunschweig, U., Sterne-Weiler, T., O’Hanlon, D., Lin, Z.-Y., Chen, G. I., Easton, L. E., Ule, J., Gingras, A.-C., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.011 · Cited by 132
“Moreover, SRm160/300 and other SR proteins have been shown to promote ESE-dependent splicing through interactions that are independent of those required for binding of U2AF65 to the polypyrimidine tract (Kan and Green, 1999; Li and Blencowe, 1999; Guth et al., 1999).”
Background
Metadata
- Authors
- Kan, J. L. C., & Green, M. R.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1999-02-15
- Volume
- 13
- Issue
- 4
- Pages
- 462-471
- ISSN
- 0890-9369 (ISSN-L)
- OpenAlex
- W2128614530
- Cited by
- 155
- References
- 0
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.